QuickRad vs CINA-iPE

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

QuickRad

by Aikenist Technologies Pvt

CINA-iPE

by Avicenna.AI

AI Verdict

QuickRad is an AI-integrated PACS and RIS system designed for comprehensive radiology workflow management, encompassing image storage, viewing, and reporting. In contrast, CINA-iPE is a specialized AI triage tool focused solely on detecting unsuspected pulmonary embolisms on CT scans to prioritize critical cases. While both operate within the radiology domain and integrate with existing workflows, QuickRad offers a broad platform solution, whereas CINA-iPE provides a targeted diagnostic AI application.

Choose QuickRad if…

Choose QuickRad if your organization requires a comprehensive, end-to-end AI-integrated PACS and RIS system to manage your entire radiology workflow, from image acquisition and storage to viewing, reporting, and analytics. It is ideal for practices looking to significantly accelerate MRI scanning, reduce reporting times, and streamline operations across all diagnostic imaging modalities with robust, FDA-cleared tools.

View QuickRad →

Choose CINA-iPE if…

Choose CINA-iPE if your primary need is to enhance the detection and prioritization of unsuspected pulmonary embolisms (iPE) across various CT scan types within your existing radiology workflow, particularly in emergency or high-volume settings. This specialized AI triage tool is best suited for augmenting current PACS/RIS systems to ensure critical cases of incidental PE are rapidly identified and addressed.

View CINA-iPE →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	QuickRad	CINA-iPE
Pricing	Aikenist generates revenue through tiered subscription plans (bronze, gold, and platinum) for its radiology workflow solutions, with pricing based on the number of scans per month.	Subscription
Deployment	On-premise or cloud hosting (private cloud environments, major cloud platforms).	Cloud-based, Locally on dedicated hardware, Locally virtualized (virtual machine, Docker).
FDA Status	1 AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

QuickRad

QuickRad offers a comprehensive suite of features for an entire radiology workflow, including a 'Zero Footprint Viewer' and 'Speech-to-Text Reporting,' which directly enhance user interaction and efficiency across multiple tasks. Its end-to-end integration suggests a streamlined experience for radiologists managing various aspects of their work.

Clinical Value

CINA-iPE

CINA-iPE directly addresses a critical clinical problem by detecting unsuspected pulmonary embolisms, enabling early treatment and preventing missed diagnoses. It provides specific, high sensitivity and specificity metrics (87.8-91.1% sensitivity, 91.8-92% specificity) for its diagnostic capability, demonstrating a clear and measurable clinical impact.

Pricing & Value

CINA-iPE

CINA-iPE utilizes a subscription model based on the number of analyses or installations, with annual or multi-year agreements, which appears to be a more straightforward and transparent pricing model. QuickRad's tiered subscription plans, with additional charges for various features and extra scans, suggest a potentially complex and escalating cost structure.

Enterprise Readiness

Tie

Both tools demonstrate strong enterprise readiness, being FDA-cleared and supporting HIPAA-compliant workflows. They also offer flexible deployment options, including cloud-based and on-premise solutions, catering to diverse IT infrastructures.

Innovation

Tie

QuickRad innovates by integrating AI across an entire PACS/RIS system, offering significant workflow accelerations like 2x faster MRI scanning and 70% reporting time reduction, alongside features like voice-enabled reporting. CINA-iPE's innovation is focused on a highly specialized AI tool for detecting *unsuspected* pulmonary embolisms, addressing a specific, high-impact clinical challenge in triage.

Support & Docs

CINA-iPE

Avicenna.AI (Tool B) explicitly mentions that 'Instructions for Use are available here' for its products and maintains a 'clinical publications repository' showcasing evidence for its solutions. While Aikenist Technologies (Tool A) provides contact information for support and is ISO 13485 certified, implying structured internal documentation, Avicenna.AI offers more explicit user-facing documentation and clinical evidence.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	QuickRad	CINA-iPE
Product Name	QuickRad	CINA-iPE
Company	Aikenist Technologies Pvt	Avicenna.AI
Core Function	FDA-cleared AI-integrated PACS and RIS system for image storage, viewing, reporting, and analytics to optimize radiology workflows and enhance clinical efficiency.	FDA-cleared AI-powered triage tool that detects unsuspected pulmonary embolisms on CT scans performed for other health conditions.
Primary AI Application	Accelerates MRI scanning 2x faster and reduces reporting time by 70%; integrated PACS/RIS with optional integration with FDA-cleared third-party AI models.	Automated detection of incidental Pulmonary Embolism (iPE) on CT scans; triage and prioritization of critical cases.
Specialties Supported	Radiology	Emergency Medicine, Pulmonology, Radiology

Videos

Demos, reviews, and walkthroughs featuring QuickRad and CINA-iPE.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate with our existing EHR and radiology workflow, and what level of disruption should we expect during implementation?

QuickRad, as an end-to-end AI-integrated PACS and RIS system, aims to optimize the entire radiology workflow, potentially involving a more significant integration effort or replacement of existing systems. CINA-iPE is designed to seamlessly integrate into existing PACS and RIS systems as an AI-powered triage tool, suggesting a less disruptive implementation focused on enhancing specific detection capabilities within current workflows.

What are the specific clinical performance metrics and diagnostic capabilities of each tool's AI components?

CINA-iPE provides specific diagnostic performance metrics, demonstrating high sensitivity (87.8-91.1%) and specificity (91.8-92%) for detecting incidental pulmonary embolisms on various CT scan types. QuickRad focuses on workflow efficiency, claiming to accelerate MRI scanning and reduce reporting time, and offers optional integration with FDA-cleared third-party AI models for diagnostic assistance.

For which specific clinical scenarios or specialties is each tool most impactful, beyond general radiology?

QuickRad is a comprehensive platform primarily designed for general radiology, aiming to optimize overall imaging workflows and reporting efficiency across various modalities and supporting AI for oncology, neurology, and cardiology. CINA-iPE is specifically tailored for Emergency Medicine and Pulmonology, providing critical AI-powered triage for unsuspected pulmonary embolisms on CT scans, enabling earlier intervention for this high-risk condition.

What is the expected learning curve for our clinical staff, and how quickly can we anticipate realizing the benefits of each tool within our practice?

Implementing QuickRad, as a full PACS/RIS system, may involve a more substantial learning curve for staff due to its comprehensive features and potential workflow overhaul, leading to a longer time-to-value as the entire system is adopted. CINA-iPE, being an integrated triage tool for a specific task, likely has a shorter learning curve and can offer faster time-to-value by immediately enhancing the detection and prioritization of pulmonary embolisms within existing workflows.

How do these tools support robust audit trails for clinical actions, AI findings, and data access, which is crucial for accountability and quality assurance?

QuickRad, as an end-to-end PACS and RIS system, inherently provides comprehensive tools for reporting and analytics, including mandatory audit trails and 180-day log retention for all actions within the system. CINA-iPE offers notification and worklist order output for AI-detected findings, which contributes to an audit trail for specific AI-driven events, though detailed audit trail features are not explicitly described.

What are the key considerations and potential challenges for deploying each tool across multiple hospital sites or clinics, particularly regarding data synchronization and workflow consistency?

QuickRad offers hybrid architecture deployment options (cloud, on-premise, or a combination) that can facilitate multi-site rollouts, with its comprehensive PACS/RIS aiming for consistent workflows and centralized data management. CINA-iPE's cloud-based or locally virtualized deployment options could also support multi-site integration into existing PACS/RIS, focusing on consistent AI-driven triage across locations.